- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03915743
Advance Care Planning Individualised Approach and Research Projec (AIR)
The AIR Project - Advance Care Planning Individualised Approach and Research Project. A Single Center Randomized Controlled Trial
Study Overview
Detailed Description
Randomised control trial. A total of 90 patients will be randomise 1:1 to either palliative intervention or standard care.
The intervention group will receive follow up in a newly established outpatient clinic for COPD in the specialized palliative united and the control group will receive standard follow up in the respiratory out-patient clinic.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Herlev/ Reghion H
-
Copenhagen, Herlev/ Reghion H, Denmark, 2730
- Herlev & Gentofte hoospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
• Diagnosis of COPD by spirometry
- Patients followed in Herlev and Gentofte hospitals' respiratory out-patient-clinics or admitted to Herlev or Gentofte hospital for acute exacerbation
- 2 or more admissions for acute exacerbation of COPD within the last 12 months
- CAT > 20
- Cognitive and linguistic able to understand and give informed consent
Exclusion Criteria:
• Expected remaining life time less than 6 months due to other disease than COPD e.g. active cancer
- Participating in other studies
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Palliative care
Specialized palliative care arm in a newly formed COPD outpatient clinic
|
complex and multi-faceted individualized palliative care
|
|
No Intervention: Usual care
Usual care in a standard pulmonary out-patient clinic.
Treatment as described in national standards.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in total Hospital and Anxiety Depression scale (HADS) at 6 months
Time Frame: baseline, 3 and 6 months
|
questionnaire measuring anxiety and Depression in 2 subscales in this study we use the total value of the 2 subscales combined.
The higher the number the worse the psychological impact.
HADS total was a range from 0 to 24 where 0 is no psychological distress
|
baseline, 3 and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline EORTC QLQ-C15-PAL at 6 months
Time Frame: baseline, 3 and 6 months
|
questionnaire, consists of 14 questions and a license audit goal from 1 to 7 where 7 is the best possible quality of life.For the first 14 questions about symptoms, the scale goes from 1 to 4 where 4 is the worst
|
baseline, 3 and 6 months
|
|
Change from Baseline Life-Space Assessment (LSA) at 6 months
Time Frame: baseline, 3 and 6 months
|
questionnaire,5 questions about where the patient has been in the last 4 weeks.
Question 1 is other than bedroom and question 5 is out of his home town.
In addition, questions are asked about how frequently and on the use of aids.finally the scales are converted to numerical value between 0 and 120 where 0 is worst and expresses that the patient is constant in bed
|
baseline, 3 and 6 months
|
|
Change from Baseline copd assessment test (CAT) at 6 months
Time Frame: baseline, 3 and 6 months
|
questionnaire. 8 items questionnaire where there should be between 0 and 5 where 5 is the worst.
Together, this gives a total scale between 0 and 40 where 40 is worst
|
baseline, 3 and 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence at 6months
Time Frame: 6 months
|
measured by inhaled medicine bought at the pharmacy.
Data is gather from a national database
|
6 months
|
|
Change from Baseline Use of out-patient clinic at 6 months
Time Frame: baseline to 6 months
|
number of out-patient clinic visits
|
baseline to 6 months
|
|
Change from Baseline in admission frequency at 6 months
Time Frame: baseline to 6 month
|
numbers of admissions in the study periode
|
baseline to 6 month
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Jens-Ulrik Jensen, Phd MD, pulmonary department Herlev and Gentofte Hospital
- Study Director: Torgny Wilcke Wilcke, phd MD, pulmonary department Herlev and Gentofte Hospital
- Study Director: Janni Mendahl, APN, Palliative Unite Herlev and Gentofte Hospital
- Study Director: Charlotte Ulrik, Prof. MD DMSc, Pulmonary department Hvidovre Hospital
- Study Chair: Nina Godtfredsen, phd MD, Pulmonary department Hvidovre Hospital
- Principal Investigator: Kristoffer Marså, MD, Palliative Unite Herlev and Gentofte Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- AIR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Severe COPD
-
Union Hospital, Tongji Medical College, Huazhong...Not yet recruitingSevere Eosinophilic ACOS (Asthma-COPD Overlap)China
-
AstraZenecaCompleted
-
Nanjing RegeneCore Biotech Co., Ltd.RecruitingModerate to Severe Chronic Obstructive Pulmonary Disease (COPD)China
-
Universidad de GranadaHospital de Alta Resolucion de Loja. Agencia Sanitaria Hospital de Poniente; Genyo-CentroPfizer-UGR-Junta Andalucia de genomica e investigacion oncologicaUnknownCOPD | COPD Exacerbation | COPD, Severe Early-OnsetSpain
-
Universitair Ziekenhuis BrusselUnknownCOPD | Severe AsthmaBelgium
-
University Medical Center GroningenUnknownChronic Obstructive Pulmonary Disease | COPD | Severe Early-Onset COPD | SEO-COPDNetherlands
-
AstraZenecaCompletedModerate to Severe COPDSweden, Bulgaria, Poland, Denmark, Slovakia
-
Hospital Universitario Reina Sofia de CordobaInstituto de Salud Carlos IIICompletedSmoking Cessation | COPD | Severe Mental DisorderSpain
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
Chiesi Farmaceutici S.p.A.CompletedModerate to Severe Chronic Obstructive Pulmonary Disease (COPD)Bulgaria, Germany, Hungary, Poland, Russian Federation, United Kingdom
Clinical Trials on palliative care
-
Allina Health SystemCompleted
-
Augusto CaraceniRecruitingCancer | Frailty | Palliative Care | Outpatient | Palliative Care, Health Services | Patient Reported Outcome Measurements | Patient Reported Outcome (PRO)Italy
-
Massachusetts General HospitalPatient-Centered Outcomes Research Institute; Palliative Care Research Cooperative...CompletedLung CancerUnited States
-
Massachusetts General HospitalPatient-Centered Outcomes Research InstituteRecruitingHigh Risk Acute Myeloid Leukemia | Relapsed Adult AML | Primary Refractory Acute Myeloid LeukemiaUnited States
-
The Hong Kong Polytechnic UniversityHospital Authority, Hong KongCompletedPalliative Care | Renal Failure, End-stageHong Kong
-
Duke UniversityNational Institute of Nursing Research (NINR)CompletedHeart Diseases | Cardiovascular Diseases | Heart FailureUnited States
-
Massachusetts General HospitalAmerican Society of Clinical OncologyCompletedNon-small Cell Lung CancerUnited States
-
University of Southern CaliforniaPatient-Centered Outcomes Research InstituteTerminatedCancer | Chronic Obstructive Pulmonary Disease | Congestive Heart FailureUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Recurrent Lung Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Caregiver | Metastatic Thymic Carcinoma | Malignant Pleural... and other conditionsUnited States
-
Al Al Bayt University, JordanKing Hussein Cancer CenterNot yet recruitingCancer | Palliative Care, Patient Care